baber/WOPTO huggingface dataset:
Patent NZ-514535-A (NZ)
Title: Cooking sink
Inventor: REID MARY J
IPC: E03C1/186
Filed: 2000-03-29
Abstract: A cooking unit (10) has a cooking chamber (16) for water which is heated and drained from a post by electrical remote controls (20, 22) which are compactly placed on the surface of the unit. In one embodiment, a basin (14) is employed with the cooking unit and affords alternative side-to-side and back-to-back movement of a cutting board (62) over the basin. Various types of cooking utensils can be employed in conjunction with the cooking chamber and the basin.
Patent NZ-515327-A (NZ)
Title: Acoustic device with a panel having a mass fixed thereto to control whole-body resonance
Inventor: ELLIS CHRISTIEN
IPC: H04R1/28
Filed: 2000-06-30
Abstract: An acoustic device has a panel (11) capable of supporting resonant bending wave modes and transducers (19) mounted on the panel.  Sometimes, the acoustic response of panel and transducers may have a whole-body resonance peak at a particular frequency.  To control this, a mass (21) may be added to the panel, for example on a compliant coupling (23).
Patent NZ-516214-A (NZ)
Title: A sorting conveyer with a tilting mechanism
Inventor: ABILDGAARD ANNE-METTE HJORTSHO
IPC: B65G47/46
Filed: 2000-05-22
Abstract: A tilting mechanism comprising an article-supporting member, such as a tray or a conveyor belt for a sorter for transporting and sorting various articles is disclosed. The article-supporting member may be held tilted about two parallel axes each being fixed with respect to the tilting part or the stationary part and being movable along a predetermined path with respect to the other part. Further is disclosed a sorter comprising article-supporting members arranged on tilting mechanisms to tilt the members when passing curves and during induction of articles from the side of the sorter so as to prevent articles from sliding off the members and thus enable the sorter to operate at much higher conveying speeds than known sorters.
Patent NZ-517143-A (NZ)
Title: Safety harness comprising a safety belt with a rip-strap (e.g. hook and loop) assembly
Inventor: PHILLIPS MARK ALEXANDER
IPC: A62B35/00
Filed: 2002-02-12
Abstract: A safety apparatus comprises a belt fitted with at least one attachment assembly located anteriorly to the user's body when the belt is worn by the user. The belt has at lest one rip-strap assembly configured to be attached to an anchoring apparatus and extend along a portion of the belt.  The anchoring apparatus is releasably securable to an anchoring point. The rip-strap assembly has a permanent attachment to the belt and has a releasable attachment to the belt wherein the attachments are on the opposing ends of the rip-straps. Also described is method of using the safety apparatus comprising securing the belt around the body of the wearer and adjusting the size of the belt until it I s a secure and conformable it and adjusting and securing the crotch and shoulder straps if fitted and securely connecting a length of safety line to the attachment device of the rip-strap at the posterior of the wearer and connecting another part of the safety line to an appropriate anchorage device.
Patent NZ-517975-A (NZ)
Title: Syringe disposal device suitable for encapsulation and disposal of a single syringe
Inventor: HERBERT JOHN
IPC: A61M5/32
Filed: 2000-10-02
Abstract: Disclosed  herein is a syringe  disposal  device  (10) suitable  for  disposal of a single syringe. The  device  is suitable  for  disposal of syringes  (30)  having  a  needle (33),  a barrel (38), a plunger (39) and on the barrel  (38) or  plunger  (39), a transversely extending  flange  portion (38a).  The  disposal  device  (10)  may  include  a  needle encapsulating  portion (12), a syringe barrel  encapsulating portion  (14)  and  a syringe retention  portion  (16).  The syringe  retention  portion (16) has an  open  end  (18)  to allow  syringe  (30) to be inserted into  device  (10).  The opposed   end   (19)  of  syringe  retention  portion   (16) communicates the retention portion (16) with syringe  barrel encapsulating  portion  (14).  Engagement  means  (20)   are provided  at,  or  proximate, the opposed end  (19)  of  the syringe  retention portion (16) for retaining  syringe  (30) within  the  disposed  device  (10)  after  passage  of  the transversely  extending  flange (38a)  past  the  engagement means (20) by interference fit. The disposal device (10)  is advantageously of tapered form.
Patent NZ-525295-A (NZ)
Title: Microprotrusion member retainer for impact applicator
Inventor: TRAUTMAN JOSEPH C
IPC: A61B17/20
Filed: 2001-10-12
Abstract: An assembly for use in stratum-corneum piercing drug delivery system that comprises:- (a) A microprotusion member (44) having a plurality of stratum-corneum piercing microprotusions thereon adapted to pierce the stratum-corneum to improve transdermal agent flux; and (b) A substaintially rigid retainer (34) having an open end adapted to be releasably attached to an impacting device (10), the retainer (34) further having an interior region that includes a retainer seat, the retainer seat being adapted to receive and position the microprotusion member (44).
Patent NZ-529885-A (NZ)
Title: Orange juice for reducing heartburns
Inventor: MCARDLE RICHARD N
IPC: A23L2/02
Filed: 2002-05-03
Abstract: Disclosed is an orange juice product produced in accordance with the following method: modifying an initial orange juice supply to have a low-acid condition and a low-oil condition, wherein said low-acid condition and said low-oil condition combine to provide an orange juice having heartburn-safeguarding characteristics. The said heartburn-safeguarding characteristics are: a titratable acidity which is not greater than about 0.7 weight percent, based upon the total weight of the orange juice product; and a concentration of citrus oil which is not greater than 0.012 volume percent, based upon the total volume of the orange juice supply.
Patent NZ-529906-A (NZ)
Title: Stereoselective method for the preparation of nucleoside analogues
Inventor: YU QING
IPC: C07D411/04
Filed: 2002-06-14
Abstract: Described is a process for producing predominantly cis nucleosides or nucleoside analogues and derivatives of formula (A): wherein R1 is a pyrimidine base or a pharmaceutically acceptable derivative thereof and Q is oxygen, carbon or sulphur, comprising a coupling step of the pyrimidine base with a molecule of formula (B) in a suitable coupling solvent, in the presence of catalytic amounts of an element or combination of elements of groups IB or IIB of the periodic table, a tertiary amine and a Lewis acid to obtain an intermediate of formula (D) which is deprotected in the subsequent step to generate the product of formula (A).
Patent NZ-533302-A (NZ)
Title: Poxvirus containing formulations and process for preparing stable, poxvirus containing compositions containing a disaaccharide and a pharmaceutically acceptable polymer i.e. dextran or polyvinylpyrrolidon (PVP)
Inventor: HOWLEY PAUL
IPC: A61K9/00
Filed: 2002-11-28
Abstract: A formulation comprises (i) a purified or partially purified poxvirus selected from Prthopoxvirus, Parapoxvirus, Avipoxvirus, Capripoxvirus and Suipoxvirus, (ii) a disaccharide (iii) a pharmaceutical acceptable polymer and (iv) a buffer wherein the buffer is not a phosphate buffer, which is useful as a vaccine. The formulation can be freeze dried to form a stable freeze dried composition.
Patent NZ-533382-A (NZ)
Title: Treatment of statin side effects using uridine derivatives
Inventor: LINNANE ANTHONY WILLIAM
IPC: A61P1/08
Filed: 2002-12-13
Abstract: Disclosed is a composition for treatment of one or more side effects of statin therapy comprising uridine, a biological precursor or derivative of uridine derived from or converted to uridine in vivo in one to four steps or a salt, ester or tautomer thereof in association with one or more pharmaceutically acceptable additives and at least one statin. Also disclosed is the use of uridine, a biological precursor or derivative of uridine derived from or converted to uridine in vivo in one to four steps or a salt, ester or tautomer thereof in preparation of a medicament for treatment of one or more side effects of statin therapy.
Patent NZ-534939-A (NZ)
Title: Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
Inventor: MEDLICOT NATALIE
Filed: 2004-08-26
Abstract: Disclosed is an injectable formulation and method of increasing the solubility and/or dispersion characteristics of a benzimidazole compound of the general formula I which is complexed with a cyclodextrin compound selected from: (a) hydroxypropyl beta-cyclodextrin compounds of formula (a) where R is CH2CHOHCH3 or H; or, (b) sulphabutyl ether beta-cyclodextrin compounds with the formula (b) where R is (CH2)4SO3Na or H; or, (c) alpha-cyclodextrin with six sugar units in the cyclodextrin ring; or, (d) gamma-cyclodextrin with eight sugar units in the cyclodextrin ring; and mixed with benzyl alcohol. The formulation is characterised by the increased solubility and/or dispersion properties of the benzimidazole compound and used in the manufacture of medicaments for the treatment of parasite infections in animals.
Patent NZ-538136-A (NZ)
Title: Purine derivatives and their use as antiproliferative agents
Inventor: FISCHER PETER
IPC: A61P25/28
Filed: 2003-08-13
Abstract: Disclosed is a compound of formula 1 wherein: One of R1 and R2 is methyl, ethyl or isopropyl and the other is H; R3 and R4 are each independently H, alkyl, or aryl and wherin at least one of R3 and R4 is other than H; R5 is alkyl or cycloalkyl each of which may be substituted with one or more OH groups; R6, R7, R8 and R9 are each independently H, halogen, NO2, OH, OMe, CH, NH2, COOH, CONH2 or SO2NH2. Compounds of the type disclosed are CDK inhibitors useful in the treatment of proliferative disorders.
Patent NZ-539150-A (NZ)
Title: Lightweight joint compound formulation for use in wallboard applications
Inventor: AYAMBEM AMBA
IPC: C04B26/32
Filed: 2003-09-30
Abstract: Wallboard joint compound compositions comprising water, calcium carbonate, a polyether siloxane copolymer, and a styrene-butadiene polymer are disclosed. The joint compound compositions display significantly reduced cratering, reduced shrinking, greater sag resistance, and excellent workability.
Patent NZ-542397-A (NZ)
Title: Static diffusion cell for diffusion sampling systems
Inventor: YANG HUA
IPC: G01N13/00
Filed: 2004-03-27
Abstract: A static diffusion cell (400) for use in a diffusion sampling apparatus is disclosed. The cell has a single chamber receptor compartment (402) with first and second outlets (408, 418) formed at the top surface of the receptor compartment, and a diffusion membrane (404) and donor compartment (410) are positioned over the first outlet. The second outlet forms a bubble trap and sampling arm (406). To facilitate the removal of bubbles the top surface of the receptor compartment may be inclined upward towards the second outlet, and/or there may be a bubble channel extending between the two outlets.
Patent NZ-542883-A (NZ)
Title: Non-toxic coating composition, methods of use thereof and articles protected from attachment of biofouling organisms
Inventor: PELZER RALF
IPC: C09D7/63
Filed: 2004-04-07
Abstract: A paint or coating composition comprising: (i) menthol and/or isopulegol; (ii) a compound of formula (II), wherein the variables are as defined in the specification; and (iii) a film forming agent; whereby the mixture of menthol and/or isopulegol and the compounds of formula (II) are present in the coating composition in an amount effective to inhibit the attachment of biofouling organisms on a surface to which the composition is applied as a coating. These compositions are used in paint, varnish and sealant formulations, particularly suitable for protecting a surface exposed to an aqueous environment from fouling organisms present in the aqueous environment or marine environment.
Patent NZ-548359-A (NZ)
Title: Method of identifying indirect agonists of insulin-like growth factor-1
Inventor: SCHAFFER MICHELLE
IPC: C07K14/65
Filed: 2002-02-01
Abstract: A method of identifying indirect agonists of IGF-1 is disclosed, which comprises the steps of: (a) comparing the ability of N,N-bis(3-D-gluconamidopropyl)-deoxycholamine to inhibit binding of IGFBP-1 or -3 to IGF-1 with the ability of a candidate indirect agonist of IGF-1 to so inhibit binding; and (b) determining whether the candidate agonist inhibits such binding at least as well as N,N-bis(3-D-gluconamidopropyl)-deoxycholamine.
Patent NZ-548724-A (NZ)
Title: Process for the production of compositions containing ribonucleotides and their use as flavouring agents
Inventor: NOORDAM BERTUS
IPC: A23L27/23
Filed: 2005-01-06
Abstract: Disclosed is a process to produce a composition containing at least 15% and less than 55% (w/w) 5'-ribonucleotides based on sodium chloride free dry matter of the composition comprising: a) subjecting a microorganism to autolysis whereby the pH is between 4.5-9 and/or the temperature is between 50-65°C under conditions at which at least 50% of the RNA remains in a form degradable into 5'-ribonucleotides and at which at least 20% of the RNA remains associated with the cell wall fraction; b) subjecting the autolysate to solid/liquid separation and recovering the RNA-containing cell wall fraction; c) converting the RNA in the recovered RNA-containing cell wall fraction into 5'-ribonucleotides.
Patent NZ-554392-A (NZ)
Title: Piperidinium derivatives including spectaline and cassine derivatives, pharmaceutic compositions containing the same and preparation process
Inventor: VIEGAS CLAUDIO
IPC: A61K31/452
Filed: 2004-10-15
Abstract: Disclosed are compounds of formulae (II) and (III), wherein R1 is other than hydrogen and the remaining substituents are as defined in the specification, processes for their preparation and pharmaceutical compositions containing them. The compounds are capable of inhibiting acetylcholinesterase, and are useful in the treatment of pathologies associated with cholinergic transmission, such as memory related disorders, neurodegenerative disorders such as Alzheimer's Disease, Myasthenia Gravis and intoxication induced by chemical agents.
Patent NZ-554761-A (NZ)
Title: Formulations comprising ecteinascidin and a disaccharide
Inventor: CALVO SALVE PILAR
IPC: A61P31/00
Filed: 2005-10-12
Abstract: Disclosed are compositions comprising of Ecteinascidin and disaccharide and methods of preparing the same. Also disclosed are methods of treating proliferative diseases with the same compositions.
Patent NZ-563099-A (NZ)
Title: Primary ans secondary seal stock laminates held together by an extruded polymeric adhesive
Inventor: MCLEAN ANDREW FENWICK
IPC: C09J7/29
Filed: 2006-04-12
Abstract: A method for producing a primary laminate (1b) including a tabstock is disclosed. The steps include feeding a seat laminate (1) comprising bottom food contact layers including a foil layer (4) and a top polyester layer (5) to a laminating station wherein either the foil layer (4) of the underside of the polyester layer (5) has been printed. Then simultaneously feeding a tabstock (6), which is narrower than the seal laminate (1) , to the laminating station such that the bottom of the tabstock and the top polyester layer of the seal laminate come into contact to form a primary substrate (1a). The top face of the primary substrate (1a) is partly comprised of the top face of the tabstock (6) and partly comprised of the top polyester layer (5) of the heat sealable laminate. Also simultaneously feeding a plastic film stock (8) which has top and bottom surfaces to the laminating station and continuously extruding a polymeric adhesive (7) between the top face of the primary substrate (1a) and bottom surface of the plastic film stock (8) such that the two are adhered together.
Patent NZ-564594-A (NZ)
Title: Clip closure system
Inventor: HASCHKE EGGO L
IPC: B65B51/04
Filed: 2006-06-15
Abstract: A clip closure system for closing clips, each clip having a base section and first and second legs extending from opposite ends thereof, is described. The clip closure system has a rail configured to hold the clips; first and second jaws which are rotatably connected to the rail; a connector; first and second arms, the first arm being connected to the first jaw and to the connector, the second arm being connected to the second jaw and to the connector; an actuator configured to move the connector such that the first jaw rotates relative to the rail to contact and bend the first leg of the clip toward the base section of the clip, and such that the second jaw rotates relative to the rail to contact and bend the second leg of the clip toward the base section of the clip.
Patent NZ-573912-A (NZ)
Title: Launch and retrieval arrangement for a kite used in the propulsion of a ship
Inventor: WRAGE STEPHAN
IPC: B63H9/06
Filed: 2006-08-15
Abstract: An aerodynamic profiled element for generating power by means of a tractive force, especially for driving watercraft is disclosed. The profiled element has a flexible top layer (111) that extends in a transversal direction and a longitudinal direction, a flexible bottom layer (112) which extends parallel to the top layer and is connected to the top layer by means of several webs (121) that run in a downward direction of the profiled element. The interior space between the top and the bottom layer is air-filled. At least one ventilation hole ventilates the interior space, and is disposed between two parallel forward edges of the top and bottom layer. Several traction lines (140) transfer the force of the wind to the watercraft. A first ends of which are fastened to the profiled element at spaced-apart points and a second ends of which are connected to a traction rope (143) for connecting the profiled element to a watercraft. A first of several reefing lines end is attached to the layers and/or webs. The reefing lines are embodied so as to reduce or increase the size of the profiled element by reefing or unreefing the top and bottom layer. The profiled element is extended by a rod element which runs in the longitudinal direction of the profiled element and is used for stabilizing the aerodynamic profile. The rod element is fastened to the top and/or bottom layer and/or a web. At least one of the reefing lines is deflected on the rod element from a reefing line section that extends from the fastening point at the first end in the transversal direction of the profiled element of the top or bottom layer into a reefing line section extending in the longitudinal direction. A launching and retrieving system is also disclosed.
Patent NZ-576337-A (NZ)
Title: Ketogenic diet
Inventor: BUTLER RAELENE
IPC: A23L33/15
Filed: 2007-10-10
Abstract: Disclosed is a solid or semi-solid nutritional product comprising proteins, lipids and digestible carbohydrates, these components originating from at least two different sources, which provides 2520-3080kilojoule per 100g dry mass, wherein the weight ratio of lipids to the sum of proteins and digestible carbohydrates is 2.7-3.4 to 1.
Patent NZ-577998-A (NZ)
Title: Disintegrin variants and pharmaceutical uses thereof
Inventor: CHUANG WOEI-JER
IPC: C07K1/00
Filed: 2007-12-21
Abstract: Provided is an isolated polypeptide selective for áãâ133 integrin, wherein the polypeptide is a variant of disintegrin with a specified amino acid sequence. Further provided are corresponding DNAs and methods of making them and using them in therapy.
Patent NZ-581199-A (NZ)
Title: Damper and damping structure for a wave energy conversion device
Inventor: HEALY ROBERT
IPC: F03B13/18
Filed: 2008-04-18
Abstract: The present invention relates to a damper for damping the reactionary motion of a wave energy conversion device to wave motion, comprising a damping energy absorber (7) having a reversible non-linear stress-strain response, arranged to damp the reactionary motion of the WEC. According to a first aspect, there is provided a damping structure (2) for a wave energy conversion device (1). The structure comprises a fixed member (6), and a damping member (7) having a reversible non-linear stress-strain response. The flexible member (7) is connectable between the fixed member (6) and a moveable member or float (3) of a wave energy conversion device (1). The invention also relates to a wave energy conversion device (1).
Patent NZ-584309-A (NZ)
Title: New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
Inventor: PEGLION JEAN-LOUIS
IPC: C07C209/46
Filed: 2010-03-29
Abstract: Disclosed is the synthesis of the compound of formula (VII) in racemic or optically active form wherein R represent a hydrogen atom or a methyl group, characterised in that the compound of formula (VIII) is reacted with the compound of formula (IX) in racemic or optically active form in the form of the free base or salt in the presence of a salt of a transition metal or of a lanthanide, in a solvent, to yield the compound of formula (X) in racemic or optically active form which is converted into the compound of formula (VII) by the action of a hydride donor agent.
Patent NZ-584335-A (NZ)
Title: Identity verification method and system
Inventor: WYN-HARRIS JEREMY
IPC: G06F11/00
Filed: 2010-08-02
Abstract: A method of assessing an entity (15) at a first user terminal (13) connected to a data network (10) and a control system (11) for facilitating entity assessment of an entity at a first user terminal connected to a data network are disclosed. The control system includes a computer system with a computer processor coupled to a system memory and programmed with computer readable instructions. The instructions are executable to receiving and processing data relating to an access request (101) from at least one of the entity (15) or an assessing user (16) at a second user terminal (14) connected to the data network; invoking or facilitating transmission of at least one unpredictable prompt for the entity to perform a visible prompted action (20); invoking storage of at least one video recording (21) of the prompted action performance from the entity in a data store (61); and invoking or facilitating transmission of the video recording from the data store and details of the prompt (18) to an second user terminal for viewing and assessment by an assessing user.
Patent NZ-584815-A (NZ)
Title: 3.4 kb mitochondrial dna deletion for use in the detection of cancer
Inventor: PARR RYAN
IPC: C12Q1/68
Filed: 2007-09-26
Abstract: Disclosed is a method of detecting a cancer in an individual comprising; a) extracting mitochondrial DNA, mtDNA, from a biological sample from the individual; b) quantifying the amount of mtDNA in the sample having a deletion in the nucleic add sequence spanning approximately residues 10744 to 14124 of the mtDNA genome; c) comparing the amount of mtDNA in the sample having the deletion to at least one known reference value, wherein the known reference value is: (i) the amount of the deletion in a reference sample of mtDNA from known non-cancerous tissue or body fluid; and/or (ii) the amount of the deletion in a reference value of mtDNA from known cancerous tissue or body fluid; - wherein, if the reference value is (i), an elevated amount of the deletion in the biological sample compared to the reference value is indicative of cancer; - and wherein, if the reference value is (ii), a similar level of the deletion in the biological sample compared to the reference value is indicative of cancer; - with the proviso that the cancer is not prostate cancer. Further disclosed is a method of monitoring an individual for the development of a cancer comprising; a) extracting mtDNA from 11 biological sample from the individual: b) quantifying the amount of mtDNA in the sample having a deletion in the nucleic acid sequence spanning approximately residues 10744 to 14124 of the mtDNA genomic; c) repeating steps a) and b) over a duration of time; d) wherein an increasing, level of the deletion over the duration of time is indicative or cancer; - with the proviso that the cancer is not prostate cancer.